NCT06739330 Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
| NCT ID | NCT06739330 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Thyroid Dysfunction |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-12-19 |
| Primary Completion | 2025-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2024-12-19 with a primary completion date of 2025-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the prevalence of thyroid dysfunction and its association with metabolic dysfunction-associated fatty liver disease.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years. * Both sexes. * Patients with metabolic dysfunction-associated fatty liver disease (MAFLD). Exclusion Criteria: * History of thyroid disease or treatment (e.g., thyroid nodules, thyroid cancer, hypothyroidism, and hyperthyroidism). * Patients with alcoholic liver disease take more than 40g of alcohol (or four units) per day. * Viral hepatitis. * Pregnant women.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06739330 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thyroid Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06739330 currently recruiting?
Yes, NCT06739330 is actively recruiting participants. Contact the research team at shaimaa.meshaal2013@med.tanta.edu.eg for enrollment information.
Where is the NCT06739330 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT06739330 clinical trial?
NCT06739330 is sponsored by Tanta University. The trial plans to enroll 150 participants.